Skip to main content

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Hepato-Pancreato-Biliary (HPB) Surgery

The Oxford Hepato-Pancreato-Biliary (HPB) surgical unit provides both a local and tertiary referral service. It serves as the tertiary referral centre for HPB diseases in the Thames Valley Cancer Network and Swindon, a population of 2.35 million.

We are a group with specialist expertise in the management of liver, pancreatic and biliary disease. This includes treatment of both benign and malignant conditions.

The HPB team includes surgeons, diagnostic/interventional radiologists, hepatologists, gastroenterologists, oncologists, and pathologists with special interest in biliary, liver and pancreatic diseases.

The Oxford HPB unit uses innovative techniques to provide quality care to patients. It is one of the few centres in the UK that is capable of offering selective internal radiotherapy (SIRT), also called radio-embolization (RE), stereotactic body radiotherapy (SBRT), and microwave ablation of liver tumours, as alternative treatment modalities along with or instead of surgery.

Patients are offered a range of surgical and non-surgical treatment options for their condition, and counselled at length prior to treatment. Where feasible, surgery is carried out through the laparoscopic (keyhole) approach.

Gallbladder and biliary disease

The HPB unit is involved in the management of gallstone disease along with benign and malignant diseases of the gallbladder. Their expertise extends to management of benign and malignant diseases involving the bile duct system that drains bile from the liver to the intestine.

Liver disease

Specialist treatment of liver diseases which include malignant tumours of the liver, for example; colorectal cancer metastases, and primary liver tumours like hepatocellular cancer (HCC) and cholangiocarcinoma are undertaken by the liver multidisciplinary team in Oxford.

Pancreatic disease

Benign pancreatic diseases like cystic tumours including intraductal papillary mucinous neoplasms (IPMN) are reviewed by the HPB multidisciplinary team in Oxford. The team also has a broad experience in the management of acute and chronic pancreatitis. Following stringent evaluation, the Oxford HPB surgical team offers total pancreatectomy and islet auto-transplantation for a select sub-set of patients with chronic pancreatitis.

Patients with pancreatic cancer and neuroendocrine tumours involving the pancreas are looked after by the Oxford HPB unit. These patients receive a personalised treatment by the specialists of the HPB multidisciplinary team.
The HPB surgical team in Oxford are also involved in the treatment of small bowel and root of mesentery tumours.

The HPB team will accept tertiary referrals without any geographical restriction. Provision of modern radical treatment, which is delivered with a low mortality and morbidity, is a key objective of the group.

The HPB surgical team believes in delivering the above mentioned care in a timely fashion to anyone referred to the service regardless of geographical area of referral.

Key staff

Consultant surgeons

  • Professor Peter Friend
  • Mr Zahir Soonawalla
  • Mr Michael A Silva
  • Mr Srikanth Reddy


  • Dr Roger W Chapman (Hepatology)
  • Dr Jane Collier (Hepatology)
  • Dr Barbara Braden
  • Dr Tony Ellis
  • Dr Adam Bailey

Medical Oncology

  • Dr Rachel Midgely
  • Dr Kinnari Patel

Clinical Oncology

  • Dr Ricky Sharma
  • Dr Somnath Mukajee
  • Dr Claire Blesing
  • Dr Nicola Warner

Interventional Radiology

  • Dr Jane Phillips-Hughes
  • Professor Fergus Gleeson
  • Dr Mark Anderson
  • Dr Phil Boardman

Cross-sectional Radiology

  • Dr Rachel R Phillips
  • Dr Andrew Slater
  • Dr Helen Bungay
  • Dr Margaret Betts


  • Dr Godman Greywoode
  • Dr Lai Mun Wang
  • Dr Caroline Hughes
  • Dr Eve Fryer

Clinical Nurse Specialists

  • Ms Sue Wilner
  • Mrs Rosie King